Peripheral Guidewires Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Peripheral Guidewires are used during percutaneous transluminal angioplasty (PTA) for guiding stents or balloon catheters to the site of blockage in the peripheral vasculature. Hydrophilic and Non-hydrophilic peripheral guidewires are tracked under this segment. GlobalData’s Medical Devices sector report provides comprehensive information about the Peripheral Guidewires pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

What are the market dynamics in the peripheral guidewires pipeline products market?

As of November 2021, 2 pipeline products were in the approval process and 4 were in the clinical stage. 3 pipeline products were in the inactive stage and less than 3 pipeline products were in the indeterminate and approved stages each. During the same period, based on pipeline products by stage of development, 2 products from SoundBite Medical Solutions Inc were in the clinical process. Similarly, Cardiovascular Systems Inc had 1 product in the in-approval process stage. The US is the leading country in the market based on pipeline products by territory, followed by Europe, Japan and the UK.

Which are the key players in the peripheral guidewires pipeline products market?

The key players in the market are Andramed GmbH, AngioDynamics Inc, Cardiovascular Systems Inc, Echopoint Medical Ltd, Guerbet SA, Navis Medical, Rontis AG, Scientia Vascular LLC, and SoundBite Medical Solutions Inc. Cardiovascular Systems Inc is the leading company in the market based on the pipeline products in the approval process, followed by Guerbet SA.

Company overview:

Andramed GmbH: Andramed GmbH (Andramed) is a medical technology company that offers niche product solutions and medical products. The company’s products include PTAcatheters, cobalt chromium bare stents, in-situ and ex-situ valvolutomies, sochman snare, flexible retrieval baskets, flexible snares, and peripheral self-expanding nitinol stents, among others. Its cobalt chromium bare stents are specifically designed for the effective treatment of large vessels. Andramed also markets its products through a network of distributors. The company serves across Chile, Argentina, Canada, Hong Kong, Indonesia, Mexico, Bangladesh, Iran, Israel, Malaysia, Singapore, Thailand, France, Germany, Australia, Poland and South Africa, among others. Andramed is headquartered in Reutlingen, Germany.

Adrion MRI Guidewire is a MR-interventional guidewire intended to be used in peripheral vascular procedures. It is designed to facilitate the placement of catheters in the peripheral vasculature. It is made of fiberplastics with a shafting of short nitinol tip to base with 5-15 cm tip and 180 cm / 300 cm length. It provides passive MR (magnetic resonance) visualization, excellent pushability, high torqueability and X-ray radiopacity. It has a polymer jacket with biocompatible hydrophilic coating.

Cardiovascular Systems Inc: Cardiovascular Systems Inc (CSI) is a medical device company that develops and commercializes products for the treatment of peripheral and coronary vascular disease. The company’s products include peripheral orbital atherectomy system, coronary orbital atherectomy system, crowns, and accessories. Its peripheral artery disease system is a percutaneous orbital atherectomy system that is used as therapy for OAS atherosclerotic disease in peripheral arteries. CSI offers accessories such as guide wires, lubricants, infusion pumps, and ancillary products. It has developed orbital atherectomy systems technology for both peripheral and coronary commercial applications. The company serves patients suffering from peripheral arterial disease and coronary artery diseases. It markets its products through its network of distributors. CSI is headquartered in St. Paul, Minnesota, the US.

Guerbet SA: Guerbet SA (Guerbet) is a manufacturer of contrast agents. The company provides a wide range of imaging products, solutions, and services for Computed Tomography (CT)/Cath Lab examinations, magnetic resonance imaging (MRI) and interventional imaging. CT/Cath Lab contrast agents consist of iodinated active ingredients and few examinations of the digestive tract use barium-based products. MRI imaging uses gadolinium complexes. Guerbet has a presence in Europe, Asia, and North and South America. The company offers products directly through its sales structure, distributors, and license-holders. Guerbet is headquartered in Villepinte, France.

Andramed GmbH: Andramed GmbH (Andramed) is a medical technology company that offers niche product solutions and medical products. The company’s products include PTA-catheters, cobalt-chromium bare stents, in-situ and ex-situ valvolutomies, sochman snare, flexible retrieval baskets, flexible snares, and peripheral self-expanding nitinol stents, among others. Its cobalt chromium bare stents are specifically designed for the effective treatment of large vessels. Andramed also markets its products through a network of distributors. The company serves across Chile, Argentina, Canada, Hong Kong, Indonesia, Mexico, Bangladesh, Iran, Israel, Malaysia, Singapore, Thailand, France, Germany, Australia, Poland, and South Africa, among others. Andramed is headquartered in Reutlingen, Germany.

AngioDynamics Inc: AngioDynamics Inc (AngioDynamics) designs, manufactures and markets minimally invasive and image-guided therapeutics and diagnostic devices. Its product portfolio encompasses vascular products, radiofrequency ablation, NanoKnife systems, vascular access products, angiographic products and accessories, products for dialysis, angioplasty, drainage, thrombolysis, and embolization, besides venous products, and renal therapy products. Its products find application in interventional radiology, interventional cardiology, and minimally invasive diagnosis and treatment of cancer and peripheral vascular disease. The company sells its products through a direct sales force in the US and through a network of distributors outside the US. AngioDynamics is headquartered in Latham, New York, the US.

Rontis AG: Rontis AG (Rontis), a subsidiary of Rontis Corporation SA, is a provider of medical devices, pharmaceuticals, infant and baby nutrition, dermaceuticals, and healthcare services. The company’s medical devices include drug-eluting stents, bare-metal stents, CTO and high-pressure balloons, guidewires for both cardiology and CTO, disposables product, and kyphoplasty set. It offers disposables for nephrology, urology, liquid administration, and anesthesiology. The company produces infant and baby nutrition and dermaceutical products. Its healthcare services include hemodialysis and dialysis. It operates through manufacturing, dialysis centers, research and development, and packaging centers. Rontis is headquartered in Zug, Switzerland.

Scientia Vascular LLC: Scientia Vascular LLC (Scientia) is a provider of access devices and therapies that are optimized to address the evolving needs of interventional specialists. The company focus on biopolymers, coatings, metals, microfabrication, manufacturing automation, and mechanical and electrical engineering for new product development. Scientia is headquartered in West Valley City, Utah, the US.

The company manufactured the Zoom 14 Guidewire that is a guide wire intended to be used during neuro and peripheral vasculature procedures. It is designed to aid in the introduction and position of catheters and other interventional devices. It consists of shapeable tip to aid in accessing vasculature, shaping mandrel, introducer, torque device. It has a polymer coating on the distal end and include a radiopaque platinum wire marker coil to facilitate fluoroscopic visualisation and polytetrafluroethylne (PTFE) coating on the proximal portion to reduce friction during manipulation in vessels.

Navis Medical: Navis Medical has developed the Variable Control Guidewire System (VCGS)an innovative guidewire technology that significantly improves endovascular navigation and eliminates or reduces the need for multiple catheters and guidewires required during invasive peripheral vascular (PV) and cardiovascular (CV) diagnostic or interventional radiologic procedures.

Peripheral guidewires pipeline products, by key players

Peripheral guidewires pipeline products, by key playersTo know more about key players, download a free report sample

Market report scope

Key countries/regions The US, Europe, the UK, and Japan
Key players Andramed GmbH, AngioDynamics Inc, Cardiovascular Systems Inc, Echopoint Medical Ltd, Guerbet SA, Navis Medical, Rontis AG, Scientia Vascular LLC, and SoundBite Medical Solutions Inc.

 Scope

  • Extensive coverage of the peripheral guidewires under development.
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details, and other developmental activities.
  • The report reviews the major players involved in the development of peripheral guidewires and lists all their pipeline projects.
  • The coverage of pipeline products based on various stages of development ranging from early development to approved / issued stage.
  • The report provides key clinical trial data of ongoing trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.
  • Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.
  • Identify and understand important and diverse types of peripheral guidewires under development.
  • Develop market-entry and market expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date.

Andramed GmbH
AngioDynamics Inc
Cardiovascular Systems Inc
Echopoint Medical Ltd
Guerbet SA
Navis Medical
Rontis AG
Scientia Vascular LLC
SoundBite Medical Solutions Inc

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 5

|1.2 List of Figures 6

2 Introduction 7

2.1 Peripheral Guidewires Overview 7

3 Products under Development 8

3.1 Peripheral Guidewires – Pipeline Products by Stage of Development 8

3.2 Peripheral Guidewires – Pipeline Products by Segment 9

3.3 Peripheral Guidewires – Pipeline Products by Territory 10

3.4 Peripheral Guidewires – Pipeline Products by Regulatory Path 11

3.5 Peripheral Guidewires – Pipeline Products by Estimated Approval Date 12

3.6 Peripheral Guidewires – Ongoing Clinical Trials 13

4 Peripheral Guidewires – Pipeline Products under Development by Companies 14

4.1 Peripheral Guidewires Companies – Pipeline Products by Stage of Development 14

4.2 Peripheral Guidewires – Pipeline Products by Stage of Development 15

5 Peripheral Guidewires Companies and Product Overview 16

5.1 Andramed GmbH Company Overview 16

5.1.1 Andramed GmbH Pipeline Products & Ongoing Clinical Trials Overview 16

5.2 AngioDynamics Inc Company Overview 17

5.2.1 AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview 17

5.3 Cardiovascular Systems Inc Company Overview 18

5.3.1 Cardiovascular Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 18

5.4 Echopoint Medical Ltd Company Overview 20

5.4.1 Echopoint Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 20

5.5 Guerbet SA Company Overview 21

5.5.1 Guerbet SA Pipeline Products & Ongoing Clinical Trials Overview 21

5.6 Navis Medical Company Overview 22

5.6.1 Navis Medical Pipeline Products & Ongoing Clinical Trials Overview 22

5.7 Rontis AG Company Overview 23

5.7.1 Rontis AG Pipeline Products & Ongoing Clinical Trials Overview 23

5.8 Scientia Vascular LLC Company Overview 24

5.8.1 Scientia Vascular LLC Pipeline Products & Ongoing Clinical Trials Overview 24

5.9 SoundBite Medical Solutions Inc Company Overview 25

5.9.1 SoundBite Medical Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview 25

6 Peripheral Guidewires- Recent Developments 29

6.1 Nov 23, 2021: OpSens Announces Fourth Quarter And Fiscal Year 2021 Financial Results 29

6.2 Nov 17, 2021: OpSens to Host Fourth Quarter Fiscal Year 2021 Financial Results Conference Call and Year-End Update on Tuesday, November 23, 2021 30

6.3 Nov 12, 2021: Asahi Intecc Announces Financial Results for the First Quarter of the Fiscal Year Ending June 2022 31

6.4 Nov 09, 2021: Rodrigo Santos Named Member of the Board of Management, Bayer AG, and President of the Crop Science Division 32

6.5 Nov 08, 2021: Boston Scientific Announces Upcoming Conference Schedule 33

6.6 Nov 04, 2021: Bayer announces Christoph Koenen as new Global Head of Clinical Development and Operations within Pharmaceuticals Research and Development at Bayer 33

6.7 Nov 04, 2021: Terumo Corp Half Yearly Results For the Period 30 September 2021 33

6.8 Nov 02, 2021: Cordis Names Muscari President Of The Americas 33

6.9 Nov 01, 2021: Japan Lifeline Announces FY3/2022 2Q Financial Results 34

6.10 Oct 28, 2021: Stereotaxis to Report Third Quarter 2021 Financial Results on November 11, 2021 34

6.11 Oct 28, 2021: Merit Medical Reports Results For Quarter Ended September 30, 2021 35

6.12 Oct 27, 2021: Boston Scientific Announces Results For Third Quarter 2021 36

6.13 Oct 05, 2021: Merit Medical Systems to Announce Third Quarter Results on October 28, 2021 40

6.14 Sep 29, 2021: OpSens to Present at the Lytham Partners Fall 2021 Investor Conference 40

6.15 Sep 09, 2021: Merit Medical Systems to Announce First Quarter Results on April 29, 2021 41

6.16 Sep 09, 2021: Boston Scientific Announces 2021 Investor Day Meeting 41

6.17 Aug 04, 2021: Terumo Revises its Full-Year Financial Guidance for FY2021 41

6.18 Aug 04, 2021: Japan Lifeline Announces FY3/2022 1Q Financial Results 41

6.19 Aug 04, 2021: Terumo Corp. Announces Consolidated Financial Results for the First Quarter Ended June 30, 2021 42

6.20 Jul 27, 2021: Cardiovascular Systems to Attend Three Investor Conferences in August 42

6.21 Jul 26, 2021: Stereotaxis Strengthens Board of Directors with Appointment of Myriam J. Curet, M.D. 43

6.22 Jul 20, 2021: Stereotaxis to Report Second Quarter 2021 Financial Results on August 10, 2021 43

6.23 Jul 13, 2021: AngioDynamics Reports Fiscal 2021 Fourth Quarter and Full-Year Financial Results 44

6.24 Jul 09, 2021: Merit Medical Systems to Announce Second Quarter Results on July 29, 2021 45

6.25 Jun 25, 2021: Japan Lifeline Notice of Resolution of the 41st Annual General Meeting of Shareholders 46

6.26 May 26, 2021: Bayer joins Greentown Labs’ Corporate Partner Network 47

6.27 May 24, 2021: Boston Scientific to Participate in Bernstein’s 37th Annual Strategic Decisions Conference 47

6.28 May 14, 2021: Asahi Intecc Announces Financial Results and Presentation Materials for the 3rd Quarter of the Fiscal Year ending June 2021 47

6.29 May 14, 2021: Asahi Intecc announces third and fourth half of the financial statements for the June period of 2021 48

6.30 Mar 30, 2021: AngioDynamics Reports Fiscal 2021 Third Quarter Financial Results and Updates Guidance 48

6.31 Mar 29, 2021: Merit Medical Reports Results for Quarter Ended March 31, 2021 49

6.32 Mar 24, 2021: Cardiovascular Systems to Participate at the 20th Annual Needham Healthcare Conference 51

6.33 Mar 22, 2021: OpSens to Present at Lytham Partners Spring 2021 Investor Conference 51

6.34 Mar 22, 2021: Terumo and Allied Telesis jointly develop a smooth operating environment for infusion systems 51

6.35 Mar 01, 2021: AngioDynamics to Present at the Barclays Virtual Global Healthcare Conference 52

6.36 Feb 17, 2021: Medtronic Executives to Speak at Upcoming Investor Conferences 52

6.37 Feb 16, 2021: Medtronic to Announce Financial Results for Its Third Quarter of Fiscal Year 2021 53

6.38 Feb 12, 2021: Merit Medical Systems to Announce Fourth Quarter and Year End 2020 Results on February 24, 2021 53

6.39 Feb 12, 2021: Boston Scientific Announces February and March 2021 Conference Schedule 53

6.40 Feb 10, 2021: Merit Medical to Present at 2021 SVB Leerink Global Healthcare Conference 53

6.41 Feb 04, 2021: Stereotaxis to Report Fourth Quarter and Full Year 2020 Financial Results on February 25, 2021 54

6.42 Feb 04, 2021: Terumo announce Financial Statements 54

6.43 Feb 04, 2021: Terumo Announces Change of Directors and Executive Officers 54

6.44 Feb 03, 2021: Cardiovascular Systems, Inc. Reports Fiscal 2021 Second-quarter Financial Results 55

6.45 Feb 01, 2021: Cardiovascular Systems announces partnership with Chansu Vascular to develop new drug-coated balloon technology 56

6.46 Jan 07, 2021: Merit Medical to Participate in Two Upcoming Investor Conferences 56

6.47 Jan 06, 2021: OpSens to Host First Quarter Fiscal Year 2021 Financial Results Conference Call on Wednesday, January 13, 2021 56

6.48 Jan 06, 2021: Abbott Hosts Conference Call for Fourth-Quarter Earnings 57

6.49 Jan 04, 2021: AngioDynamics to Present at the J.P. Morgan Virtual Healthcare Conference 57

6.50 Dec 28, 2020: Cook Medical launches a new Customer Portal to enhance customer experience 57

7 Appendix 58

7.1 Methodology 58

7.2 About GlobalData 61

7.3 Contact Us 61

Table

Peripheral Guidewires – Pipeline Products by Stage of Development 8

Peripheral Guidewires – Pipeline Products by Segment 9

Peripheral Guidewires – Pipeline Products by Territory 10

Peripheral Guidewires – Pipeline Products by Regulatory Path 11

Peripheral Guidewires – Pipeline Products by Estimated Approval Date 12

Peripheral Guidewires – Ongoing Clinical Trials 13

Peripheral Guidewires Companies – Pipeline Products by Stage of Development 14

Peripheral Guidewires – Pipeline Products by Stage of Development 15

Andramed GmbH Pipeline Products & Ongoing Clinical Trials Overview 16

Adrion MRI Guidewire – Product Status 16

Adrion MRI Guidewire – Product Description 16

AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview 17

Adx – Product Status 17

Adx – Product Description 17

Cardiovascular Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 18

Next Gen Guide Wire – Product Status 18

Next Gen Guide Wire – Product Description 18

PAD Radial Guidewire – Product Status 19

PAD Radial Guidewire – Product Description 19

Echopoint Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 20

iKOs Guidewire – Peripheral Vascular – Product Status 20

iKOs Guidewire – Peripheral Vascular – Product Description 20

Guerbet SA Pipeline Products & Ongoing Clinical Trials Overview 21

Microguidewire – Product Status 21

Microguidewire – Product Description 21

Navis Medical Pipeline Products & Ongoing Clinical Trials Overview 22

Variable Control Guidewire System – Product Status 22

Variable Control Guidewire System – Product Description 22

Rontis AG Pipeline Products & Ongoing Clinical Trials Overview 23

Peripheral Guidewire – 0.035 – Product Status 23

Peripheral Guidewire – 0.035 – Product Description 23

Scientia Vascular LLC Pipeline Products & Ongoing Clinical Trials Overview 24

Zoom 14 Guidewire – Product Status 24

Zoom 14 Guidewire – Product Description 24

SoundBite Medical Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview 25

SoundBite Crossing System – Peripheral – ATK – Product Status 25

SoundBite Crossing System – Peripheral – ATK – Product Description 25

SoundBite Crossing System – Peripheral – BTK – Product Status 26

SoundBite Crossing System – Peripheral – BTK – Product Description 26

SoundBite Medical Solutions Inc – Ongoing Clinical Trials Overview 27

SoundBite Crossing System – Peripheral – BTK – Prospective Study on the Clinical Effectiveness, Safety, Cost Benefits and Outcomes of the SoundBite Crossing System in Complex Peripheral CTOs – The PROSPECTOR II Study 28

Figures

Peripheral Guidewires – Pipeline Products by Stage of Development 8

Peripheral Guidewires – Pipeline Products by Segment 9

Peripheral Guidewires – Pipeline Products by Territory 10

Peripheral Guidewires – Pipeline Products by Regulatory Path 11

Peripheral Guidewires – Pipeline Products by Estimated Approval Date 12

Frequently asked questions

Peripheral Guidewires Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021 thematic reports
Currency USD
$2,500

Can be used by individual purchaser only

$7,500

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Peripheral Guidewires Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021 was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Peripheral Guidewires Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021 in real time.

  • Access a live Peripheral Guidewires Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021 dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.